lundi 7 septembre 2015

Onco Actu du 7 septembre 2015


3.1 Tabac

Pfizer's quit-smoking drug not linked to depression or heart risks [Reuters]

High schoolers use e-cigarettes to vape marijuana: U.S. study [Reuters]

4. Dépistage, diagnostic et pronostic

Preventing Overdiagnosis 2015 [HealthNewsReview]

5. Traitements

NICE joins project to make development of new treatments more efficient [NICE]

5.12 Immunothérapies

CAR-T Follow Up [In the Pipeline]

5.2 Pharma

Genzyme vets raise $37.5M for a new cancer biotech [FierceBiotech]

AstraZeneca to update on leading lung cancer portfolio at WCLC 2015 [AstraZeneca]

5.2.1 Pharma - Partenariats

Horizon to Advance Redx's Pan-RAF Inhibitors against Cancer [GEN]

5.2.3 Pharma - économie

Celgene threatens to scale back UK clinical trial investment after CDF snub [Pharmafile]

5.3.4 Traitements - AMM (FDA, EMA)

Novartis wins EU approval for multiple myeloma drug Farydak [Reuters]

5.4 Traitements - Economie

Webinar: Experts Discuss Soaring Drug Prices And How Reporters Can Cover The Story [Reporting on Health]

Twenty-three therapies axed from Cancer Drugs Fund [PharmaTimes]

Cancer drugs fund cuts 23 treatments [BC News]

Cancer charities condemn NHS England for axing medicines [The Guardian]

6. Lutte contre les cancers

World Conference on Lung Cancer Opens with Focus on Global Collaboration [Colorado Cancer Blogs]

Dr Giles Maskell: ‘waiting a month or more for scan results is shocking’ [Cancer Research UK]

Tests to diagnose cancer underfunded and staff overstretched [Cancer Research UK]

Breast cancer care quality threatened by lack of specialist nurses [The Guardian]

6.6 Publications

Investigation leads to retraction of breast cancer paper, second for one author [Retraction Watch]

6.9 Controverses

UT Chancellor Mandates Unprecedented Shared Governance Structure at MD Anderson [The Cancer Letter]